Exhibit A
AGREEMENT
The undersigned agree that this Amendment No. 4 to Schedule 13G dated February 14, 2022 relating to the Common Stock, par value $0.001 per share, of ReShape Lifesciences Inc. shall be filed on behalf of the undersigned.
Armistice Capital, LLC | ||
By: | /s/ Steven Boyd | |
Steven Boyd | ||
Managing Member |
/s/ Steven Boyd | ||
Steven Boyd |